All entries for: Krystal Biotech

February 17, 2026

Krystal Biotech

Neutral Outlook

Pittsburgh, PA
201-500 employees

It is unclear whether the Trump administration executive orders will lead to actual legislative initiatives. At this time, we continue to evaluate the effect of the IRA and the Trump administration’s executive actions on our business operations and financial condition and results as the full impact of the IRA and the executive actions remains uncertain.

Disease Area: Dermatology, Oncology, Other, Respiratory Diseases
Drug Type: Small Molecule
November 20, 2025

Krystal Biotech

Orphan Drug Designation

Pittsburgh, PA
201-500 employees

FDA orphan drug designation: treatment of Hailey-Hailey disease (HHD)

Disease Area: Rare Diseases
Scroll to Top